Concepedia

Steven M. Leventer

SM

Statistics

Publications

12

Citations

480

H-Index

11

Active since

1982

Affiliations

UCB Pharma (Belgium)(Current)

University of Pittsburgh

The University of Texas Medical Branch at Galveston

Vedantra Pharmaceuticals (United States)

Steven M. Leventer is an author at UCB Pharma (Belgium) specializing in pharmacology, cholinergic pharmacology, and cholinergic neurochemistry.

Publications per year

1982–2007

12

Publications

12

Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo

Steven M. Leventer, Ernst Wülfert, Israel Hanin · Neuropharmacology · 1987 · 83 citations

Pharmacy, Pharmacology, Toxicology +14

Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices

Steven M. Leventer, Dennish W. McKeag, Michael Clancy et al. · Neuropharmacology · 1985 · 78 citations

Life Sciences, Neuroscience, Pharmacology +11

The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With Anxiety

Arifulla Khan, G. Virginia Upton, Richard L. Rudolph et al. · Journal of Clinical Psychopharmacology · 1998 · 77 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Clinical trial: dextofisopam in the treatment of patients with diarrhoea‐predominant or alternating irritable bowel syndrome

Steven M. Leventer, Karen Raudibaugh, Christine L. Frissora et al. · Alimentary Pharmacology & Therapeutics · 2007 · 75 citations

Medicine, Pharmacology, Pharmacotherapy +16

Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.

Thomas W. Vickroy, Melanie Watson, Steven M. Leventer et al. · Journal of Pharmacology and Experimental Therapeutics · 1985 · 43 citations

Medicine, Neuroscience, Pharmacology +16

1–5 of 12